Beneficial role of aminoguanidine on acute cardiomyopathy related to doxorubicin-treatment

Molecular and Cellular Biochemistry

Volumn 285, Issue 1-2, 2006, Pages 149-154

  Cigremis, Yilmaz ^a   Parlakpinar, Hakan ^b   Polat, Alaadin ^b   Colak, Cemil ^c   Ozturk, Feral ^b   Sahna, Engin ^d   Ermis, Necip ^b   Acet, Ahmet ^b  

^a KAFKAS UNIVERSITY   (Turkey)

^b INONU UNIVERSITY   (Turkey)

^c Republic of Turkey Prime Ministry   (Turkey)

^d FIRAT UNIVERSITY   (Turkey)

Author keywords

Aminoguanidine; Cardiomyopathy; Doxorubicin; Thiobarbituric acid reactive substances

Indexed keywords

AMINOGUANIDINE; ANTHRACYCLINE ANTIBIOTIC AGENT; ANTIOXIDANT; DOXORUBICIN; FREE RADICAL; GLUTATHIONE; SCAVENGER; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CANCER CHEMOTHERAPY; CARDIOMYOPATHY; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; HEART INJURY; HEART MUSCLE FIBROSIS; HEART PROTECTION; INFLAMMATORY CELL; MORPHOLOGY; NONHUMAN; RAT; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; TISSUE INJURY;

ACUTE DISEASE; ANIMALS; CARDIOMYOPATHIES; DOXORUBICIN; GLUTATHIONE; GUANIDINES; HEART; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE II; RATS; REACTIVE OXYGEN SPECIES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

ANIMALIA;

EID: 33646123097     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-005-9072-8     Document Type: Article

References (40)

1. Hsiu-Chuan Y, Terry DO, Satit V, Ye-Shih H, Daret KSC: The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J Clin Invest 98: 1253-1260, 1996
2. Siveski-Iliskovic N, Kaul N, Singal PK. Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation 89: 2829-2835, 1994
3. Sahna E, Parlakpinar H, Ozer MK, Ozturk F, Ozugurlu F, Acet A: Melatonin protects against myocardial doxorubicin toxicity in rats: Role of physiological concentrations. J Pineal Res 35: 257-261, 2003
4. Xu MF, Ho S, Qian ZM, Tang PL: Melatonin protects against cardiac toxicity of doxorubicin in rat. J Pineal Res 31: 301-307, 2001
5. Hrelia S, Fiorentini D, Maraldi T, Angeloni C, Bordoni A, Biagi PL, Hakim G: Doxorubicin induces early lipid peroxidation associated with changes in glucose transport in cultured cardiomyocytes. Biochim Biophys Acta 1567: 150-156,2002
6. Quiles JL, Huertas JR, Battino M, Mataix J, Ramirez-Tortosa MC: Antioxidant nutrients and adriamycin toxicity. Toxicology 180: 79-95, 2002
7. Singal PK, Iliskovic N: Doxorubicin-induced cardiomyopathy. N Engl J Med 339: 900-905, 1998
8. Naidu MU, Kumar KV, Mohan IK, Sundaram C, Singh S: Protective effect of Gingko biloba extract against doxorubicin-induced cardiotoxicity in mice. Indian J Exp Biol 40: 894-900, 2002
9. Pacher P, Liaudet L, Bai P, Mabley JG, Kaminski PM, Virag L, et al: Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation 107: 896-904, 2003
10. Alfonso T, Carlos F, Patricia S, Elena de B, Patricio A: Effect of glutathione depletion on antitumor drug toxicity (apoptosis and necrosis) in U-937 human promonocytic cells. J Biol Chem 276: 47107-47115, 2001
11. Parlakpinar H, Tasdemir S, Polat A, Bay-Karabulut A, Vardi N, Ucar M, et al: Protective effect of gentamicin-induced nephrotoxicity by protein kinase C inhibitor; chelerythrine. Cell Biochem Funct: In Press, 2004
12. Wahab MH, Akoul ES, Abdel-Aziz AA: Modulatory effects of melatonin and vitamin E on doxorubicin-induced cardiotoxicity in Ehrlich ascites carcinoma-bearing mice. Tumori 86: 157-162, 2000
13. Fadillioglu E, Erdogan H, Sogut S, Kuku I: Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats. J Appl Toxicol 23: 71-74, 2003
14. Li T, Danelisen I, Singal PK: Early changes in myocardial antioxidant enzymes in rats treated with adriamycin. Mol Cell Biochem 232: 19-26, 2002
15. Garcia JJ, Reiter RJ, Guerrero JM, Escames G, Yu BP, Oh CS, Munoz-Hoyos A: Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett 408: 297-300, 1997
16. Misko TP, Moore WM, Kasten TP, Nickols GA, Corbett JA, Tilton RG, et al: Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 233: 119-125, 1993
17. Sugimoto K, Yagihashi S: Effects of aminoguanidine on structural alterations of microvessels in peripheral nerve of streptozotocin diabetic rats. Microvasc Res 53: 105-112, 1997
18. Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, et al: Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation endproduct formation. Diabetes 42: 221-231, 1993
19. Ihm SH, Yoo HJ, Park SW, Ihm J: Effect of aminoguanidine on lipid peroxidation in streptozotocin induced diabetic rats. Metabolism 48: 1141-1145, 1999
20. Szabo C, Ferrer-Sueta G, Zingarelli B, Southan GJ, Salzman AL, Radi R: Mercaptoethylguanidine and guanidine inhibitors of nitric-oxide synthase react with peroxynitrite and protect against peroxynitrite-induced oxidative damage. J Biol Chem 272: 9030-9036, 1997
21. Aoki K, Ohmori M, Takimoto M, Ota H, Yoshida T: Cocaine-induced liver injury in mice is mediated by nitric oxide and reactive oxygen species. Eur J Pharmacol 336: 43-49, 1997
22. Shiomi M, Wakabayashi Y, Sano T, Shinoda Y, Nimura Y, Ishimura Y, Suematsu M: Nitric oxide suppression reversibly attenuates mitochondrial dysfunction and cholestasis in endotoxemic rat liver. Hepatology 27: 108-115, 1998
23. Al-Shabanah OA, Alam KS, Nagi MN, Al-Rikabi AC, Al-Bekairi AM: Protective effect of aminoguanidine, a nitric oxide synthase inhibitor, against carbon tetrachloride induced hepatotoxicity in mice. Life Sci 66: 265-270, 2000
24. Mansour MA, Mostafa AM, Nagi MN, Khattap MM, Al-Shabanah OA: Protective effect of aminoguanidine against nephrotoxicity induced by cisplatin in normal rats. Comparative Biochemistry and Physiology Part C 132: 123-128, 2002
25. Mostafa AM, Nagi MN, Al Rikabi AC, Al-Shabanah OA, El-Kashef HA: Protective effect of aminoguanidine against cardiovascular toxicity of chronic doxorubicin treatment in rats. Res Commun Mol Pathol Pharmacol 106: 193-202, 1999
26. Parlakpinar H, Sahna E, Ozer MK, Ozugurlu F, Vardi N, Acet A: Physiological and pharmacological concentrations of melatonin protect against cisplatin induced acute renal injury. J Pineal Res 33: 1-6, 2002
27. Sahna E, Parlakpinar H, Ozturk F, Cigremis Y, Acet A: Protective effects of physiological and pharmacological concentrations of melatonin on renal ischemia-reperfusion injury in rats. Urol Res 31: 188-193, 2003
28. Bompart GJ, Prevot DS, Bascands JL: Rapid automated analysis of glutathione reductase, peroxidase, and S-transferase activity: application to cisplatin-induced toxicity. Clin Biochem 23: 501-504, 1990
29. Agapito MT, Antolin Y, del Brio MT, Lopez-Burillo S, Pablos MI, Recio JM: Protective effect of melatonin against adriamycin toxicity in the rat. J Pineal Res 311: 23-30, 2001
30. Xu MF, Tang PL, Qian ZM, Ashraf M: Effects of doxorubicin on the myocardium are mediated by oxygen free radicals. Life Sci 68: 889-901, 2001
31. McCord JM: Human disease, free radicals, and the oxidant/antioxidant balance. Clin Biochem 26: 351-357, 1993
32. Wolff SP: Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the etiology of diabetes mellitus and complications. Br Med Bull 49: 642-652, 1993
33. Seiler N, Knodgen B, Bartholeyns J: Polyamine metabolism and polyamine excretion in normal and tumor bearing rodents. Anticancer Res 4: 371-377, 1985
34. Yildiz G, Demiryurek AT, Sahin-Erdemli I, Kanzik I: Comparison of antioxidant activities of aminoguanidine, methyl-guanidine and guanidine by luminal-enhanced chemiluminescence. Br J Pharmacol 124: 905-910, 1998
35. Giardino I, Fard AK, Hatchell DL, Brownlee M: Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis. Diabetes 47: 1114-1149, 1998
36. Wozniak G, Anuszewska EL: Influence of vitamins C and E on cytotoxic activity of adriamycin in chosen cell cultures. Acta Pol Pharm 59: 31-35, 2002
37. Dziegiel P, Jethon Z, Suder E, Sopel M, Rabczynski J, Surowiak P, Zabel M: Role of exogenous melatonin in reducing the cardiotoxic effect of daunorubicin and doxorubicin in the rat. Exp Toxicol Pathol 53: 433-439, 2002
38. Boucher F, Coudray C, Tirard V, Barandier C, Tresallat N, Favier A, de Leiris J: Oral selenium suplementation in rats reduces cardiac toxicity of adriamycin during ischemia and reperfusion. Nutrition 11: 708-711, 1995
39. Sun X, Zhou Z, Kang YJ: Attenuation of doxorubicin toxicity in metallothionein-overexpressing transgenic mouse heart. Cancer Res 61: 3382-3387, 2001
40. Santos DL, Moreno AJ, Leino RL, Froberg MK, Wallace KB: Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy. Toxicol Appl Pharmacol 185: 218-227, 2002